Atlas Trials

Gastrointestinal Tolerability Study Of Dimethyl Fumarate In Participants With Relapsing-Remitting Multiple Sclerosis In Germany

Clinical trial NCT02125604 · COMPLETED

Trial details

NCT number
NCT02125604
Sponsor
Biogen
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Relapsing-Remitting Multiple Sclerosis
Start date
2014-06-01
Primary completion
2016-02-01
Enrollment
214

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.